[1]巴明玉,娄永强,禄保平△.健脾疏肝降脂方干预非酒精性脂肪肝病肥胖小鼠肝功能、游离脂肪酸机制探讨*[J].陕西中医,2020,(4):434-436.
　BA Mingyu,LOU Yongqiang,LU Baoping..Effect and mechanism of Jianpi Shugan Jiangzhi recipe on liver function and FFA in NAFLD obese mice[J].,2020,(4):434-436.
点击复制

健脾疏肝降脂方干预非酒精性脂肪肝病肥胖小鼠肝功能、游离脂肪酸机制探讨*
分享到：

《陕西中医》[ISSN:1000-7369/CN:61-1281/TN]

卷:
期数:
2020年4期
页码:
434-436
栏目:
基础研究
出版日期:
2020-04-05

文章信息/Info

Title:
Effect and mechanism of Jianpi Shugan Jiangzhi recipe on liver function and FFA in NAFLD obese mice
文章编号:
DOI:10.3969/j.issn.10007369.2020.04.008
作者:
巴明玉1; 娄永强2; 禄保平3△
1.河南中医药大学第一附属医院(郑州450000); 2.河南省通许县中医院(通许 475400); 3.河南中医药大学(郑州 450046)
Author(s):
BA Mingyu; LOU Yongqiang; LU Baoping.
The First Affiliated Hospital of Henan University of Chinese Medicine(Zhengzhou 450000)
关键词:
健脾疏肝降脂方;  非酒精性脂肪肝;  肥胖;  模型小鼠;  肝功能;  游离脂肪酸
Keywords:
Jianpi Shugan Jiangzhi Recipe;  Non-alcoholic fatty liver;  Obesity;  Model mice;  Liver function;  Free fatty acid
分类号:
R575
文献标志码:
A
摘要:
目的:观察健脾疏肝降脂方治疗非酒精性脂肪肝(NAFLD)肥胖小鼠ALT、AST、FFA及光镜下病理组织学改变,并与壳脂胶囊治疗组比较,观察其疗效。方法:将72只小鼠随机分为模型组、健脾疏肝降脂方高、中、低剂量组、壳脂胶囊对照组和空白组。采用饲养高脂饲料及皮下注射5%CCl4复制NAFLD肥胖小鼠模型,分别以相应药物灌胃6周,检测血清中ALT、AST及FFA的含量,光镜下观察肝组织的脂肪变程度。结果:①各个用药组相比模型组,血清ALT、AST均降低有统计学意义(P<0.01),且中药各浓度组较壳脂胶囊组血清ALT、AST降低,差异有统计学意义(P<0.05); 中药高、中剂量组相比模型组FFA降低,比较有统计学意义(P<0.05); 但与壳脂胶囊组相比,中药各剂量组改善FFA,差异无明显统计学意义(P>0.05)。②光镜可见:各用药组光镜下病理组织改变均较模型组明显,以中、高剂量组较低剂量组小鼠肝细胞脂肪变程度减轻较明显。结论:健脾疏肝降脂方能有效降低NAFLD肥胖小鼠的肝功能、其与浓度无关; 可以降低FFA及改善光镜下肝脏的脂肪变,其有效程度与浓度有一定的关系。
Abstract:
Objective:To observe the histopathological changes of ALT,AST,FFA and light microscope in the treatment of NAFLD obese mice by Jianpi Shugan Jiangzhi Recipe.And compared with the treatment group of shell fat capsule to observe the curative effect.Methods:Seventy-two mice were randomly divided into the model group,the high-dose,medium-dose and low-dose groups of Jianpi Shugan Jiangzhi Recipe,the shell fat capsule control group and the blank group.High-fat diet and subcutaneous injection of 5%CCL-4 were used to replicate NAFLD in obese mice,and corresponding drugs were given to the mice for 6 weeks,The contents of ALT、AST and FFA in serum were detected,The degree of fatty change in liver tissue was observed under light microscope.Results:①Compared with the model group, the serum ALT and AST levels of each treatment group were significantly lower(P<0.01).In addition,the serum ALT and AST levels in each concentration group of traditional Chinese medicine were significantly lower than those in the shell fat capsule group(P<0.05); Compared with the model group, FFA in the high-dose and medium-dose groups of traditional Chinese medicine decreased significantly(P<0.05).However,compared with the shell fat capsule group,the improvement of FFA in each dose group of traditional Chinese medicine was not statistically significant(P>0.05).②The histopathological changes were more obvious in each group under light microscope than in the model group,Among them,the medium and high dose group and low dose group mice hepatocyte fatty change extent reduce obviously.Conclusion:Jianpi Shugan Jiangzhi Recipe can effectively reduce liver function in obese NAFLD rats,it has nothing to do with the concentration; It can reduce FFA and improve hepatic adiposis under light microscope,The effective degree is related to the concentration.

参考文献/References:

[1] 王 燕,马 燕,吴琦琦,等.非酒精性脂肪性肝病进展性肝纤维化危险因素分析[J].胃肠病学和肝病学杂志,2019,28(1):96-100.
[2] Wang XH,Li CY,Muhammad I,et al.Fatty acid composition in serum correlates with that in the liver and non-alcoholic fatty liver disease activity scores in mice fed a high-fat diet[J].Environmental Toxicology and Pharmacology,2016,44:140-150.
[3] 魏 伟,吴希美,李元健.药理实验方法学[M].4版.北京:人民卫生出版社,2010:1128.
[4] 陈 奇.中药药理研究方法学[M].3版.北京:人民卫生出版社,2011:229-230.
[5] 吴凤燕,钱形邦.多种血清学指标检验诊断脂肪肝的应用及结果分析[J].中国现代药物应用,2017,11(15):79-80.
[6] 韩佳佳,刘 霜,段钟平,等.非酒精性脂肪性肝病中肝细胞脂肪变性分子机制的研究[J].胃肠病学和肝病学杂志,2018,27(10):1103-1109.
[7] 李保良,张 琪,林冠凯,等.健脾化痰汤含药血清对胰岛素抵抗3T3-L1脂肪细胞蛋白质表达的影响[J].中医药导报,2018,24(16):20-25.
[8] 张海博,王 宇.非酒精性脂肪肝现代研究进展[J].海南医学,2017,28(10):1651-1653.
[9] 王 艳,涂 萍,徐定波,等.脂肪因子及游离脂肪酸与非酒精性脂肪肝相关性研究[J].中国现代医生,2018,56(25):17-19.
[10] Liu C,Chen J,Li E,et al.The comparison of antioxidative and hepatoprotective activities of Codonopsis pilosula polysaccharide(CP)and sulfated CP[J].International Immunopharmacology,2015,24(2):299-305.
[11] 李 滢,杨秀伟.生白术化学成分研究[J].中国现代中药,2018,20(4):382-386.
[12] 岳美颖.茯苓主要药理作用及临床应用[J].亚太传统医药,2016,12(7):68-69.
[13] 于蓓蓓,闫雪生,孙丹丹.山楂药理作用及其机制研究进展[J].中南药学,2015,13(7):745-748.
[14] 赵兴旺,周 慢,朱宇溪,等.陈秋教授“以通为法”并巧配桑叶荷叶治疗肥胖经验[J].云南中医中药杂志,2018,39(5):3-5.
[15] 赵卫云.我院降脂茶的药理作用研究概况分析[J].光明中医,2018,33(24):3762-3764.

相似文献/References:

[1]李 勤,谢冰昕△,靳 敏,等.从虚、郁、痰、瘀论治2型糖尿病合并非酒精性脂肪肝*[J].陕西中医,2020,(5):653.[doi:DOI:10.3969/j.issn.10007369.2020.05.028]

备注/Memo

备注/Memo:
*河南省教育厅科学技术研究重点项目(13A360611)
更新日期/Last Update: 2020-04-13